Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-25-029854

Director bought 168 shares at an average $5.11 ($858)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jones James Director 2025-05-01 Purchase 10b5-1 +8 $4.86 $39 43,008 D
Jones James Director 2025-05-02 Purchase 10b5-1 +8 $4.75 $38 43,016 D
Jones James Director 2025-05-05 Purchase 10b5-1 +8 $4.68 $37 43,024 D
Jones James Director 2025-05-06 Purchase 10b5-1 +8 $4.60 $37 43,032 D
Jones James Director 2025-05-07 Purchase 10b5-1 +8 $4.71 $38 43,040 D
Jones James Director 2025-05-08 Purchase 10b5-1 +8 $4.50 $36 43,048 D
Jones James Director 2025-05-09 Purchase 10b5-1 +8 $4.78 $38 43,056 D
Jones James Director 2025-05-12 Purchase 10b5-1 +8 $5.25 $42 43,064 D
Jones James Director 2025-05-13 Purchase 10b5-1 +8 $5.67 $45 43,072 D
Jones James Director 2025-05-14 Purchase 10b5-1 +8 $5.68 $45 43,080 D
Jones James Director 2025-05-15 Purchase 10b5-1 +8 $5.20 $42 43,088 D
Jones James Director 2025-05-16 Purchase 10b5-1 +8 $5.37 $43 43,096 D
Jones James Director 2025-05-19 Purchase 10b5-1 +8 $4.92 $39 43,104 D
Jones James Director 2025-05-20 Purchase 10b5-1 +8 $5.41 $43 43,112 D
Jones James Director 2025-05-21 Purchase 10b5-1 +8 $5.05 $40 43,120 D
Jones James Director 2025-05-22 Purchase 10b5-1 +8 $5.10 $41 43,128 D
Jones James Director 2025-05-23 Purchase 10b5-1 +8 $5.14 $41 43,136 D
Jones James Director 2025-05-27 Purchase 10b5-1 +8 $5.27 $42 43,144 D
Jones James Director 2025-05-28 Purchase 10b5-1 +8 $5.68 $45 43,152 D
Jones James Director 2025-05-29 Purchase 10b5-1 +8 $5.66 $45 43,160 D
Jones James Director 2025-05-30 Purchase 10b5-1 +8 $4.93 $39 43,168 D
Open-market purchases · 168 sh · avg $5.11 · $858
Loading xslF345X05/wk-form4_1749213516.xml…